Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

OBJECTIVES: The NAnoliPOsomaL Irinotecan (NAPOLI-1) study (NCT01494506) was the largest global phase 3 study in a post-gemcitabine metastatic pancreatic adenocarcinoma (mPAC) population (N = 417). The subanalyses reported here investigated the prognostic effect of tumor characteristics and disease s...

Descripción completa

Detalles Bibliográficos
Autores principales: Macarulla Mercadé, Teresa, Chen, Li-Tzong, Li, Chung-Pin, Siveke, Jens T., Cunningham, David, Bodoky, György, Blanc, Jean-Frédéric, Lee, Kyung-Hun, Dean, Andrew, Belanger, Bruce, Wang-Gillam, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946097/
https://www.ncbi.nlm.nih.gov/pubmed/31856081
http://dx.doi.org/10.1097/MPA.0000000000001455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946097/
https://www.ncbi.nlm.nih.gov/pubmed/31856081
http://dx.doi.org/10.1097/MPA.0000000000001455

Ejemplares similares